Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7786)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2018 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang XW, Ye JZ, Li YT, Li LJ. Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis. World J Gastroenterol 2018; 24(28): 3181-3191 [PMID: 30065564 DOI: 10.3748/wjg.v24.i28.3181] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i28/3181.htm |
| Number | Citing Articles |
| 1 |
Viola Guardigni, Bianca Granozzi, Lorenzo Badia, Silvia Galli, Isabella Bon, Gabriella Verucchi. HBsAg seroreversion in HBsAg-negative/HBcAb-positive patients with HIV infection treated with direct-acting antivirals for HCV: A retrospective study. Digestive and Liver Disease 2020; 52(4): 466 doi: 10.1016/j.dld.2020.01.010
|
| 2 |
Jerzy Jaroszewicz, Małgorzata Pawłowska, Krzysztof Simon, Dorota Zarębska-Michaluk, Beata Lorenc, Jakub Klapaczyński, Magdalena Tudrujek-Zdunek, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Katarzyna Paluch, Dorota Dybowska, Iwona Buczyńska, Agnieszka Czauż-Andrzejuk, Hanna Berak, Rafał Krygier, Maciej Piasecki, Beata Dobracka, Jolanta Citko, Anna Piekarska, Łukasz Socha, Zbigniew Deroń, Olga Tronina, Łukasz Laurans, Jolanta Białkowska, Krzysztof Tomasiewicz, Waldemar Halota, Robert Flisiak. Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA. Expert Review of Anti-infective Therapy 2020; 18(10): 1045 doi: 10.1080/14787210.2020.1782189
|
| 3 |
Andy Tien, Amandeep Sahota, Su-Jau Yang, Ronald Balbuena, Mimi Chang, Carolina Lim, Tse-Ling Fong. Prevalence and Characteristics of Chronic Hepatitis C Among Asian Americans Are Distinct From Other Ethnic Groups. Journal of Clinical Gastroenterology 2021; 55(10): 884 doi: 10.1097/MCG.0000000000001447
|
| 4 |
Hesham El-Khayat, Mostafa Yakoot, Mortada El-Shabrawi, Yasser Fouad, Dina Attia, Enas M. Kamal. Treatment of Chronic Hepatitis C in Adolescent Patients With Positive HBsAg or With Occult Hepatitis B: Is the Risk of Hepatitis B Reactivation Significant?. Pediatric Infectious Disease Journal 2021; 40(1): 11 doi: 10.1097/INF.0000000000002894
|
| 5 |
Min Li, Jie Yang, Yinxia Zhao, Yahui Song, Shengxia Yin, Jing Guo, Hongkai Zhang, Kezhen Wang, Lin Wei, Shuijun Li, Wei Xu. MCPIP1 inhibits Hepatitis B virus replication by destabilizing viral RNA and negatively regulates the virus-induced innate inflammatory responses. Antiviral Research 2020; 174: 104705 doi: 10.1016/j.antiviral.2020.104705
|
| 6 |
Manal H. El-Sayed, Zeinab N.A. Said, Enas K. Abo-Elmagd, Fatma S.E. Ebeid, Iman I. Salama. High Risk of HBV Infection Among Vaccinated Polytransfused Children With Malignancy. Journal of Pediatric Hematology/Oncology 2021; 43(1): e45 doi: 10.1097/MPH.0000000000001887
|
| 7 |
Zahra Dossaji, Lubaba Haque, Adam Khattak, Mark Hsu, Robert Gish. A Review of Hepatitis B Reactivation Risk on Immunosuppressants with a Focus on Newer Immunomodulators. Current Hepatology Reports 2024; doi: 10.1007/s11901-024-00662-7
|
| 8 |
Galal Yahya, Nashwa Hashem Mohamed, Jordi Pijuan, Noura M. Seleem, Rasha Mosbah, Steffen Hess, Ahmed A. Abdelmoaty, Rafa Almeer, Mohamed M. Abdel‐Daim, Hamoud Shulaywih Alshaman, Ibrahim Juraiby, Kamel Metwally, Zuzana Storchova. Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeast. Microbial Biotechnology 2021; 14(5): 2199 doi: 10.1111/1751-7915.13904
|
| 9 |
Lixia Guo, Dan Wang, Xiping Ouyang, Ni Tang, Xuemei Chen, Yuhong Zhang, Hongquan Zhu, Xiaosong Li. Recent Advances in HBV Reactivation Research. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/2931402
|
| 10 |
Nehna Abdul Majeed, Ahmad Samer Alawad, Kin Seng Liem, Varun Takyar, Harvey Alter, Jordan J. Feld, Harry L. A. Janssen, Marc G. Ghany. Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy. Digestive Diseases and Sciences 2023; 68(7): 3193 doi: 10.1007/s10620-023-07916-2
|
| 11 |
Massimo Giuseppe Colombo, Erkin Isakovich Musabaev, Umed Yusupovich Ismailov, Igor A Zaytsev, Alexander V Nersesov, Igor Anatoliyevich Anastasiy, Igor Alexandrovich Karpov, Olga A Golubovska, Kulpash S Kaliaskarova, Ravishankar AC, Sanjay Hadigal. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology 2019; 25(29): 3897-3919 doi: 10.3748/wjg.v25.i29.3897
|
| 12 |
Rosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García. ¿Cuándo puede ser útil buscar VHB oculto en pacientes en hemodiálisis?. Nefrología 2020; 40(2): 115 doi: 10.1016/j.nefro.2019.07.001
|
| 13 |
Bárbara Cancho Castellano, Rosa María Ruiz-Calero Cendrero, María Victoria Martín Hidalgo-Barquero, Rosa Díaz Campillejo, Cristina López Arnaldo, Nicolás Roberto Robles Pérez-Monteoliva. Nuevos aspectos en la vigilancia epidemiológica con relación a las enfermedades virales en hemodiálisis. Nefrología 2020; 40(5): 570 doi: 10.1016/j.nefro.2019.09.009
|
| 14 |
Rosa María Ruiz-Calero Cendrero, Bárbara Cancho Castellano, María Victoria Martín Hidalgo-Barquero, María Cruz Cid Parra, Josefa Galán González, María Antonia Fernández Solís, Olga Sánchez García. When can it be useful to look for occult HBV in haemodialysis patients?. Nefrología (English Edition) 2020; 40(2): 115 doi: 10.1016/j.nefroe.2020.03.008
|
| 15 |
Kali Zhou, Norah A. Terrault. Hepatitis B Virus and Liver Disease. 2021; : 339 doi: 10.1007/978-981-16-3615-8_15
|
| 16 |
Kazuhiro Murai, Hayato Hikita, Yugo Kai, Yasuteru Kondo, Makoto Fukuoka, Keisuke Fukutomi, Akira Doi, Takuo Yamai, Tasuku Nakabori, Ryo Fukuda, Takeshi Takahashi, Kei Miyakawa, Hiroshi Suemizu, Akihide Ryo, Ryoko Yamada, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. Hepatitis C virus infection suppresses hepatitis B virus replication via the RIG-I-like helicase pathway. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57603-9
|
| 17 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 231 doi: 10.2174/9789815123432123010012
|
| 18 |
Imre Kovesdi, Tibor Bakacs. Therapeutic Exploitation of Viral Interference. Infectious Disorders - Drug Targets 2020; 20(4): 423 doi: 10.2174/1871526519666190405140858
|
| 19 |
Shang-Chin Huang, Hung-Chih Yang, Jia-Horng Kao. Hepatitis B reactivation: diagnosis and management. Expert Review of Gastroenterology & Hepatology 2020; 14(7): 565 doi: 10.1080/17474124.2020.1774364
|
| 20 |
Muzammil M Khan, Mukarram J Ali, Hira Hanif, Muhammad H Maqsood, Imama Ahmad, Javier E G Alvarez, Maria-Andreea Catana, Daryl T Y Lau. The dilemma of cytomegalovirus and hepatitis B virus interaction. Gastroenterology Report 2022; 10 doi: 10.1093/gastro/goac018
|
| 21 |
Xinhua Zou, Qingyu Xu, Ran You, Guowen Yin. Efficacy and Safety of TACE Combined with Regorafenib Plus PD-1 Inhibitor in the Treatment of Hepatocellular Carcinoma After Sorafenib Resistance. Journal of Hepatocellular Carcinoma 2023; : 267 doi: 10.2147/JHC.S399874
|
| 22 |
Laszlo Szereday, Matyas Meggyes, Timea Berki, Attila Miseta, Nelli Farkas, Judit Gervain, Alajos Par, Gabriella Par. Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C. Clinical and Experimental Medicine 2020; 20(2): 219 doi: 10.1007/s10238-020-00618-3
|
| 23 |
Zeinab Nabil Ahmed Said, Manal Hamdy El-Sayed. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings. World Journal of Hepatology 2022; 14(7): 1333-1343 doi: 10.4254/wjh.v14.i7.1333
|
| 24 |
|
| 25 |
Rachael Jacob, Mark Danta. Pharmacotherapeutic strategies for hepatitis B and hepatitis C coinfection. Expert Opinion on Pharmacotherapy 2022; 23(4): 465 doi: 10.1080/14656566.2021.2019708
|
| 26 |
Mindie H. Nguyen, Grace Wong, Edward Gane, Jia-Horng Kao, Geoffrey Dusheiko. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews 2020; 33(2) doi: 10.1128/CMR.00046-19
|
| 27 |
Bárbara Cancho Castellano, Rosa María Ruiz-Calero Cendrero, María Victoria Martín Hidalgo-Barquero, Rosa Díaz Campillejo, Cristina López Arnaldo, Nicolás Roberto Robles Pérez-Monteoliva. New aspects in epidemiological surveillance in relation to viral diseases in haemodialysis. Nefrología (English Edition) 2020; 40(5): 570 doi: 10.1016/j.nefroe.2019.09.006
|
| 28 |
Joo Hyun Oh, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun, Sang Bong Ahn. Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 2022; 12(12): 1957 doi: 10.3390/jpm12121957
|
| 29 |
Wei-Liang Shih, Chi-Tai Fang, Pei-Jer Chen. Viruses and Human Cancer. Recent Results in Cancer Research 2021; 217: 325 doi: 10.1007/978-3-030-57362-1_13
|
| 30 |
Zhen Ye, Tong-Shi-Yao Zhao, Shan-Bin Li, Xian-Li Zhou, Qin Luo, Jiang-Ke Qin, Cheng-Qin Liang, Ping Wang, Guang-Bo Ge. Synthesis and biological evaluation of esculetin derivatives as potential anti-HBV agents. Medicinal Chemistry Research 2023; 32(5): 899 doi: 10.1007/s00044-023-03045-7
|